Related Experiment Video
Updated: Apr 7, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
The Complexities of the Diagnosis and Management of Kawasaki Disease
1Department of Pediatrics, Northwestern University Feinberg School of Medicine, 310 East Superior Street, Morton 4-685B, Chicago, IL 60611, USA.
Insights
Kawasaki disease (KD) requires prompt diagnosis and treatment in children with prolonged fever. Early intervention with intravenous immunoglobulin and aspirin is crucial to prevent severe cardiac complications.
Area of Science:
- Pediatrics
- Cardiology
- Infectious Diseases
Background:
- Kawasaki disease (KD) is a critical pediatric illness.
- Delayed diagnosis of KD can lead to severe cardiac sequelae, including coronary artery aneurysms and death.
- KD should be considered in febrile children presenting with compatible clinical and laboratory findings.
Purpose of the Study:
- To emphasize the importance of considering Kawasaki disease in the differential diagnosis of febrile children.
- To highlight the necessity of prompt therapeutic intervention for Kawasaki disease.
- To outline the standard and alternative treatment strategies for Kawasaki disease.
Main Methods:
- Literature review of Kawasaki disease diagnosis and treatment.
- Analysis of clinical and laboratory features indicative of KD.
- Review of therapeutic responses to standard and alternative treatments for KD.
Main Results:
- Kawasaki disease must be included in the differential diagnosis for children with prolonged fever (4-5 days) and relevant clinical/laboratory signs.
- Infants with prolonged fever and compatible laboratory findings, even without classic signs, warrant KD consideration.
- Most patients respond to initial therapy, but some require additional treatments.
Conclusions:
- Prompt diagnosis and treatment of Kawasaki disease are essential to prevent long-term cardiac complications.
- Intravenous immunoglobulin and aspirin are the primary treatments for KD.
- A subset of patients may require further therapeutic interventions beyond the initial regimen.
Abstract:
Kawasaki disease (KD) must be considered in the differential diagnosis of any child with fever for 4 to 5 days and compatible clinical and laboratory features, and in any infant with prolonged fever and compatible laboratory features, even in the absence of the classic clinical signs. Prompt therapy is required, because delayed or unrecognized KD can lead to lifelong heart disease or death in previously healthy children. Most children with KD respond to a single 2 g/kg dose of intravenous gammaglobulin with oral aspirin, but a small subset require additional therapies to resolve the clinical illness.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Myocarditis III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis III: Medical Management
Myocarditis IV: Nursing Management

